GlassScriptPhysician profile
Debra Ann Reilly
NPI 1740231877
$41,277.24
in general payments reported to CMS, 2019-2025
14 companies · $5,576 in 2025
The $5,576 reported for 2025 was more than what 93% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $2,052 · 2021: $14K · 2022: $4,965 · 2023: $170 · 2024: $184 · 2025: $5,576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,325 · Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,325.00 |
| Food and Beverage | $605.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $11,481.22 | 2020-2023 | |
| Allergan, INC. | $8,591.74 | 2019-2021 | |
| Merz North America, INC. | $6,120.00 | 2021 | |
| Integra Lifesciences Corporation | $5,325.00 | 2025 | Integra |
| Mallinckrodt Enterprises LLC | $5,003.67 | 2019 | |
| Mallinckrodt Hospital Products INC. | $3,750.00 | 2020-2022 | |
| Urgo Medical North America, LLC | $251.24 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Kerecis Limited | $218.40 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Avita Medical Americas, LLC | $157.23 | 2019 | |
| Davol INC. | $135.27 | 2019 | |
| Polynovo North America LLC | $114.12 | 2019-2023 | |
| Innovation Technologies INC | $74.61 | 2024 | Irrisept |
| Smith+Nephew, INC. | $39.80 | 2024 | Oasis, Stravix, Grafix Pl |
| Convatec INC. | $14.94 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Reilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.